Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 2/20 | 0.50 |
| ▸ | SHBG | P04278 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | PGR | P06401 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5325123 | 0.88 | AR (0.64) | ARSHBGLMNAMAPTPGR | |
| SCHEMBL13125419 | 0.86 | SHBG (0.52) | ARSHBGPGR | |
| SCHEMBL3453564 | 0.86 | SHBG (0.52) | ARSHBGPGR | |
| SCHEMBL14569123 | 0.82 | AR (0.45) | ARSHBGLMNAMAPTPGR | |
| SCHEMBL5327817 | 0.82 | AR (0.45) | ARSHBGLMNAMAPTPGR | |
| SCHEMBL5334484 | 0.82 | AR (0.45) | ARSHBGLMNAMAPTPGR | |
| SCHEMBL3452256 | 0.81 | SHBG (0.46) | ARSHBGPGR | |
| SCHEMBL3452488 | 0.79 | AR (0.78) | ARSHBGLMNAMAPTPGR | |
| SCHEMBL5030906 | 0.79 | AR (0.78) | ARSHBGLMNAMAPTPGR | |
| SCHEMBL3452180 | 0.79 | AR (0.78) | ARSHBGLMNAMAPTPGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7820642-B2 | Nandrolone 17β-carbonates | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2010-10-26 | — | — | US | disclosed |
| US-20080167283-A1 | Nandrolone 17 Beta-Carbonates | GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRE- SENTED BY THE SECRETARY, DEPA (US) | 2008-07-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080167283-A1 | Nandrolone 17 Beta-Carbonates | HSD3B1, HSD3B2, HSD17B7 | AR 90/4885SHBG 22/4885LMNA 1090/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.